[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352228-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-352228-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","pan-cancer-multi-omics-reveals-dcaf7-as-an-immune-modulating-prognostic-driver-and-wnt-catenin-activator-in-hepatocellular-carcinoma","Pan-cancer multi-omics reveals DCAF7 as an immune-modulating prognostic driver and Wnt/β-catenin activator in hepatocellular carcinoma","","Background: DCAF7 is a WD-repeat adaptor that recruits substrates to the CUL4-DDB1 ubiquitin ligase complex, with its pan-cancer relevance and mechanistic role in tumor progression still unclear. Methods: Multi-omics datasets from 33 tumor types were integrated to define DCAF7 expression, regulation, and clinical significance, and immune associations were assessed. Results: DCAF7 was overexpressed across most cancers and linked to immune checkpoint upregulation and poorer prognosis in hepatocellular carcinoma. Mechanistic work in LIHC supports β-catenin stabilization and proliferative signaling, with therapeutic vulnerability to targeted agents.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-multi-omics-reveals-dcaf7-as-an-immune-modulating-prognostic-driver-and-wnt-catenin-activator-in-hepatocellular-carcinoma/352228/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-multi-omics-reveals-dcaf7-as-an-immune-modulating-prognostic-driver-and-wnt-catenin-activator-in-hepatocellular-carcinoma/352228.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is DCAF7 and why is it important in this study?","Question",{"text":63,"@type":64},"DCAF7 is a WD-repeat adaptor involved in recruiting substrates to the CUL4-DDB1 ubiquitin ligase complex. The study focuses on clarifying its pan-cancer relevance and its mechanistic contribution to tumor progression.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were DCAF7 expression and clinical relevance analyzed?",{"text":68,"@type":64},"Multi-omics datasets from 33 tumor types were integrated to evaluate DCAF7 expression, regulation, somatic alterations, copy-number variation, promoter methylation, and RNA modification signatures. Immune associations were assessed using computational deconvolution and checkpoint-gene profiling.",{"name":70,"@type":61,"acceptedAnswer":71},"What key findings link DCAF7 to immune regulation and prognosis in hepatocellular carcinoma?",{"text":72,"@type":64},"In hepatocellular carcinoma, high DCAF7 expression correlated with CD4+ T-cell infiltration, immune checkpoint gene upregulation, and increased tumor mutational burden. DCAF7 alterations were associated with worse overall survival.",{"name":74,"@type":61,"acceptedAnswer":75},"How does DCAF7 influence Wnt/β-catenin signaling in LIHC?",{"text":76,"@type":64},"The study reports that DCAF7 stabilizes β-catenin through enhanced GSK-3β Ser9 phosphorylation, driving c-Myc and cyclin D1 expression. This contributes to proliferation and migration in hepatocellular carcinoma cells.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},352228,1790154946,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":33,"preview_urls":151},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","DOI: 10.1002/ctm2.70572  \nRESEARCH ARTICLE  \nPan-cancer multi-omics reveals DCAF7 as an  \nimmune-modulating prognostic driver and Wnt/β-catenin activator in hepatocellular carcinoma  \nRuina Luan1   Hanbin Lin2   Xin Zhao1, 3  Jianpeng Li4  Maohe Chen2   Shiping Luo5  Xinjian Lin2, 6  \n1 School of Basic Medical Sciences, Key Laboratory of Translational Tumor Medicine in Fujian Province, Putian University, Putian, Fujian, China  \n2 Central Laboratory, Affiliated Hospital of Putian University, Putian, Fujian, China  \n3 Department of Pediatric Orthopaedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China  \n4 Department of Breast Surgery, Affiliated Hospital of Putian University, Putian, Fujian, China  \n5 Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China  \n6 Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China  \nCorrespondence  \nXinjian Lin, Central Laboratory, Affiliated Hospital of Putian University, Putian, Fujian 351100, China and Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fujian Medical University, Fuzhou, Fujian 350122, China.  \n[Email:](Email: xlin@fjmu.edu.cn)[ xlin@fjmu.edu.cn](Email: xlin@fjmu.edu.cn)  \nShiping Luo, Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian 350014, China.  \nEmail: [shipingluo0627@gmail.com](shipingluo0627@gmail.com)  \nMaohe Chen, Central Laboratory, Affiliated Hospital of Putian University, Putian, Fujian 351100, China. [Email:](Email: Nefelibata_chen@outlook.com)[ Nefelibata_chen@outlook.com](Email: Nefelibata_chen@outlook.com)  \nGraphical Abstract  \nClin. Transl. Med. 2026;16:e70572 .  \n[https://doi.org/10.1002/ctm2.70572](https://doi.org/10.1002/ctm2.70572)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nLUAN et al.  \n1. DCAF7 is up-regulated in various tumours and correlates with poor prognosis, particularly in LIHC.  \n2. High DCAF7 expression is linked to CD4+ T cell infiltration, up-regulation of immune checkpoint genes and increased tumour mutational burden, suggesting a role in tumour immune escape.  \n3. DCAF7 stabilises β-catenin by enhancing GSK-3β Ser9 phosphorylation, thereby driving c-Myc/cyclin D1 expression and contributing to proliferation and migration in LIHC.  \n4. DCAF7-high tumours demonstrate therapeutic vulnerability to 17-AAG, docetaxel and CDK/GSK-3 inhibitor, revealing potential targeted treatment strategies.  \nDOI: 10.1002/ctm2.70572  \nRESEARCH ARTICLE  \nPan-cancer multi-omics reveals DCAF7 as an  \nimmune-modulating prognostic driver and Wnt/β-catenin activator in hepatocellular carcinoma  \nRuina Luan1   Hanbin Lin2   Xin Zhao1, 3  Jianpeng Li4  Maohe Chen2   Shiping Luo5  Xinjian Lin2, 6  \n1 School of Basic Medical Sciences, Key Laboratory of Translational Tumor Medicine in Fujian Province, Putian University, Putian, Fujian, China 2 Central Laboratory, Affiliated Hospital of Putian University, Putian, Fujian, China  \n3 Department of Pediatric Orthopaedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China  \n4 Department of Breast Surgery, Affiliated Hospital of Putian University, Putian, Fujian, China  \n5 Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China  \n6 Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, Fujian, China  \nCorrespondence  \nXinjian Lin, Central Laboratory, Affiliated Hospital of Putian University, Putian, Fujian 351100, China and Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fujian Medical University, Fuzhou, Fujian 350122, China. [Email:](Email: xlin@fjmu.edu.cn)[ xlin@fjmu.edu.cn](Email: xlin@fjmu.edu.c","cbCailfVnrAJFFVw","https://ap.wps.com/l/cbCailfVnrAJFFVw","pdf",11009612,29,"English","# Background\n# Methods\n# Results\n# Mechanistic and Functional Validation","[{\"question\":\"What is DCAF7 and why is it important in this study?\",\"answer\":\"DCAF7 is a WD-repeat adaptor involved in recruiting substrates to the CUL4-DDB1 ubiquitin ligase complex. The study focuses on clarifying its pan-cancer relevance and its mechanistic contribution to tumor progression.\"},{\"question\":\"How were DCAF7 expression and clinical relevance analyzed?\",\"answer\":\"Multi-omics datasets from 33 tumor types were integrated to evaluate DCAF7 expression, regulation, somatic alterations, copy-number variation, promoter methylation, and RNA modification signatures. Immune associations were assessed using computational deconvolution and checkpoint-gene profiling.\"},{\"question\":\"What key findings link DCAF7 to immune regulation and prognosis in hepatocellular carcinoma?\",\"answer\":\"In hepatocellular carcinoma, high DCAF7 expression correlated with CD4+ T-cell infiltration, immune checkpoint gene upregulation, and increased tumor mutational burden. DCAF7 alterations were associated with worse overall survival.\"},{\"question\":\"How does DCAF7 influence Wnt/β-catenin signaling in LIHC?\",\"answer\":\"The study reports that DCAF7 stabilizes β-catenin through enhanced GSK-3β Ser9 phosphorylation, driving c-Myc and cyclin D1 expression. This contributes to proliferation and migration in hepatocellular carcinoma cells.\"}]","Pan-cancer multi-omics reveals DCAF7 as an immune-modulating prognostic driver and Wnt/β-catenin activator in hepatocellular carcinoma | PDF",1790098432,73,[152,156,160,164],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43e544db80e37929fa7225008e246704.webp",983,1291,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e33af6fa82303a09dde142a3bf5ac806.webp",982,1290,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd0d3a7d7f00e0d6759bc15a83416fa9.webp",981,1289,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f634858d56579fb523db8a9ba2c2e3b3.webp",980,1287]